Quality of life of people diagnosed with dementia or memory impairment who are at risk of wandering or getting lost Mental and Behavioural Disorders Unspecified dementia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals must have a designated family member/close friend who will supervise the use of the device including being able to access and use the accompanying software. 2. Nominated friend must not be any member of paid care staff 3. Participants must live in an area served by South West Yorkshire Partnership NHS Trust memory services 4. Individuals must be either living in their own homes or in supported accommodation
Exclusion criteria
Exclusion criteria: 1. If an individual does not have a close family member identified at the outset, he/she will be excluded from the study 2. If participants move out of this area to a different locality before the end of six months duration of the study, they will cease to be part of the study 3. If individuals make a permanent move to a 24-hour residential care setting, they will cease to be part of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of participants who need admission to a 24-hour care facility such as a hospital, nursing home or residential home, measured using monthly check-in calls and/or post-trial supportive contact for 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of times the GPS tracker has been used to retrieve the wearer, measured by liaising with individual dyads during monthly and post-trial supportive contacts for 6 months 2. Number of hospital admissions as a result of wandering, measured using the Revised Algase wandering scale at baseline (within 2 weeks before joining the study) and follow-up (end of 6 months in the study) 3. Number of times the police have needed to be contacted due to an incidence of wandering, measured using the Revised Algase wandering scale at baseline and follow-up, and review of police records 3. Quality of life of both wearer and carer, measured using the Zarit Burden interview questionnaire and Cornell-Brown Quality of life index at baseline (before joining the study) and follow-up (end of 6 months of joining the study) 4. Usability and acceptability of the product measured using the UoAlberta GPS useability questionnaire (Wearer & Carer) at follow up (end of 6 months of study) | — |
Countries
England, United Kingdom